[Serum S100B protein and stage of cutaneous melanoma: a prospective study].

@article{Brouard2000SerumSP,
  title={[Serum S100B protein and stage of cutaneous melanoma: a prospective study].},
  author={Maitane Brouard and Ve´ronique Quillien and Isabelle Ollivier and Thierry Lesimple and Henri Adamski and Jacqueline Chevrant-Breton},
  journal={Annales de dermatologie et de venereologie},
  year={2000},
  volume={127 1},
  pages={56-9}
}
OBJECTIVE We searched for a correlation between serum S100B protein and cutaneous malignant melanoma stage, according to the American Joint Committee on Cancer staging system, and between elevation of serum S100B protein and development of metastasis. PATIENTS AND METHODS We conducted a prospective bicentric study for 20 months in 122 patients with malignant melanoma. LIA-mat(R) assay was used to determine serum S100B at each examination. The optimal cut-off value was determined from the ROC… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-2 of 2 extracted citations

Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG • 2013

Similar Papers

Loading similar papers…